Detalles de la búsqueda
1.
Emerging biomarkers in metastatic urothelial carcinoma: tumour mutational burden, PD-L1 expression and APOBEC polypeptide-like signature in a patient with complete response to anti-programmed cell death protein-1 inhibitor.
Ecancermedicalscience
; 15: 1306, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34824629
Resultados
1 -
1
de 1
1
Próxima >
>>